Vaccinating Pregnant Women Protects Infants Against Severe RSV

The vaccine RSVpreF had an almost 82% efficacy against severe RSV infection in infants from birth through the first 90 days of life, according to company data.

Related Keywords

Germany ,Thomas Mertens ,Ortwin Adams ,Markus Rose ,Science Media Center ,Institute For Virology At Ulm University Hospital ,Institute For Virology Of The University Hospital ,Drug Administration ,Data Monitoring Committee ,Pfizer ,Standing Committee On Vaccination ,Robert Koch Institute ,University Hospital ,Pediatric Pulmonology ,Standing Committee ,Ulm University Hospital ,Prefusionf Specific ,Pregnancy ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Vaccine ,Influenza ,Flu ,Pneumonia ,Combined Tdap Vaccine ,Ombined Tetanus Diphtheria Pertussis Vaccine ,Tdap Vaccine ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Biologic Therapy ,Immunizations ,Vaccination ,Pediatric Respiratory Infections ,Ediatric Respiratory Syncytial Virus Infection ,Ediatric Rsv Infection ,Ediatric Cold ,Ediatric Common Col ,